TY - JOUR
T1 - Opioid Prescribing Recommendations after Mohs Micrographic Surgery and Reconstruction
T2 - A Delphi Consensus
AU - Donigan, Jessica M.
AU - Srivastava, Divya
AU - Maher, Ian
AU - Abdelmalek, Mark
AU - Bar, Anna A.
AU - Blalock, Travis W.
AU - Bordeaux, Jeremy S.
AU - Brodland, David G.
AU - Carroll, Bryan T.
AU - Council, Martha Laurin
AU - Duffy, Keith
AU - Fathi, Ramin
AU - Golda, Nicholas
AU - Johnson-Jahangir, Hillary
AU - Konda, Sailesh
AU - Leitenberger, Justin J.
AU - Moye, Molly
AU - Nelson, Jenny L.
AU - Patel, Vishal A.
AU - Shaffer, Joseph J.
AU - Soltani-Arabshahi, Razieh
AU - Tristani-Firouzi, Payam
AU - Tschetter, Amanda J.
AU - Nijhawan, Rajiv I.
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - BACKGROUNDPrescription opioids play a large role in the opioid epidemic. Even short-term prescriptions provided postoperatively can lead to dependence.OBJECTIVETo provide opioid prescription recommendations after Mohs micrographic surgery (MMS) and reconstruction.METHODSThis was a multi-institutional Delphi consensus study consisting of a panel of members of the American College of Mohs Surgery from various practice settings. Participants were first asked to describe scenarios in which they prescribe opioids at various frequencies. These scenarios then underwent 2 Delphi ratings rounds that aimed to identify situations in which opioid prescriptions should, or should not, be routinely prescribed. Consensus was set at ≥80% agreement. Prescription recommendations were then distributed to the panelists for feedback and approval.RESULTSTwenty-three Mohs surgeons participated in the study. There was no scenario in which consensus was met to routinely provide an opioid prescription. However, there were several scenarios in which consensus were met to not routinely prescribe an opioid.CONCLUSIONOpioids should not be routinely prescribed to every patient undergoing MMS. Prescription recommendations for opioids after MMS and reconstruction may decrease the exposure to these drugs and help combat the opioid epidemic.
AB - BACKGROUNDPrescription opioids play a large role in the opioid epidemic. Even short-term prescriptions provided postoperatively can lead to dependence.OBJECTIVETo provide opioid prescription recommendations after Mohs micrographic surgery (MMS) and reconstruction.METHODSThis was a multi-institutional Delphi consensus study consisting of a panel of members of the American College of Mohs Surgery from various practice settings. Participants were first asked to describe scenarios in which they prescribe opioids at various frequencies. These scenarios then underwent 2 Delphi ratings rounds that aimed to identify situations in which opioid prescriptions should, or should not, be routinely prescribed. Consensus was set at ≥80% agreement. Prescription recommendations were then distributed to the panelists for feedback and approval.RESULTSTwenty-three Mohs surgeons participated in the study. There was no scenario in which consensus was met to routinely provide an opioid prescription. However, there were several scenarios in which consensus were met to not routinely prescribe an opioid.CONCLUSIONOpioids should not be routinely prescribed to every patient undergoing MMS. Prescription recommendations for opioids after MMS and reconstruction may decrease the exposure to these drugs and help combat the opioid epidemic.
UR - http://www.scopus.com/inward/record.url?scp=85102090471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102090471&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000002551
DO - 10.1097/DSS.0000000000002551
M3 - Article
C2 - 32769528
AN - SCOPUS:85102090471
SN - 1076-0512
VL - 47
SP - 167
EP - 169
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 2
ER -